Memphis Cancer Center — Memphis, Tennessee

Memphis Cancer Center is a clinical research site located in Memphis, Tennessee, United States.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

Memphis Cancer Center has participated in 8 clinical trials.

Therapeutic areas: Hormone-Refractory Prostate Cancer, Prostatic Neoplasms, Breast Cancer.

Sponsors: Astellas Pharma Inc, Novartis, Sanofi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Memphis

Browse all research sites in Tennessee · View every site in Memphis

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Memphis Cancer Center?

Memphis Cancer Center has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Memphis Cancer Center conducted?

Memphis Cancer Center has 8 clinical trials on record. Their work covers Hormone-Refractory Prostate Cancer, Prostatic Neoplasms, Breast Cancer.

Is Memphis Cancer Center accredited by Crixeo Clinical Trials?

Memphis Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Memphis Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.